Lattice Biologics

Lattice Biologics Ltd., a biotech company, develops, manufactures, and markets biologics products for use in the field of bone regeneration in dental, spine, and general orthopedic indications worldwide. It develops acellular demineralized bone scaffold, a human cortical bone demineralized that are used in various applications in orthopedic, neurological, trauma, oral/maxillofacial, and reconstructive procedures; and acellular dermal matrix that provides a natural collagen tissue scaffold that promotes cellular ingrowth, tissue vascularization, and regeneration The company also develops amniotic fluid-based products, such as AmnioBoost and AmnioBlast. In addition, it sells traditional allografts for multi-disciplinary applications, including orthopedics, neurology, podiatry, and oral/maxillofacial. The company was founded in 2013 and is headquartered in Belgrade, Montana.

Our mission is to be the leader in providing advanced tissue engineering and tissue-based products to aid in the preservation and regeneration of musculoskeletal, orthopaedic and orthobiologic applications.

Our vision is to create a healthier future for patients worldwide, improving their quality of life and providing advanced tissue-based solutions to the healthcare community.

Lattice Biologics Inc. is the recipient of numerous awards and recognition such as Top 25 Most Innovative Companies, American Regenerative Medicine Company of the Year award, and Top 100 Women Led Businesses.